GGrantIndex
← Leaderboards

Ivo Kalajzic

University Of Connecticut Sch Of Med/Dnt

$9,010,720
Attributed
$10,117,438
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,117,438 · 7

By mechanism

R01$9,141,052 · 4
R21$757,346 · 2
R03$219,040 · 1

Top collaborators

Most similar at University Of Connecticut Sch Of Med/Dnt

Same institution · by research overlap

Others in their field

Top investigators on “Osteoblasts

Research focus

OsteoblastsTissuesIn VivoCellsMesenchymal Stem CellsFractureSignal TransductionMouse ModelBoneOsteocytesChondrocytesComplexCell LineageFutureStem CellsOsteogenesisIn VitroBaseEvaluationHealingExhibitsMechanicsSourceBone Healing

Grant awards (30)

Notch signaling and Bone Fracture Healing$531,918
R01 · FY2025 · AR · contact PI
CGRP-CLR mediated regulation of bone healing$397,849
R01 · FY2025 · AR · contact PI
Cellular Therapy for Osteogenesis Imperfecta$386,481
R01 · FY2025 · AR · contact PI
Notch signaling and Bone Fracture Healing$533,141
R01 · FY2024 · AR · contact PI
CGRP-CLR mediated regulation of bone healing$404,096
R01 · FY2024 · AR · contact PI
Notch signaling and Bone Fracture Healing$560,953
R01 · FY2023 · AR · contact PI
CGRP-CLR mediated regulation of bone healing$417,221
R01 · FY2023 · AR · contact PI
Notch signaling and Bone Fracture Healing$587,424
R01 · FY2022 · AR · contact PI
Growth Factor Based on Enhancement of Bone Repair$340,373
R01 · FY2021 · AR · contact PI
Growth Factor Based on Enhancement of Bone Repair$350,900
R01 · FY2020 · AR · contact PI
Notch Signaling and Bone Fracture Healing$350,900
R01 · FY2019 · AR · contact PI
Growth Factor Based on Enhancement of Bone Repair$350,900
R01 · FY2019 · AR · contact PI
Notch Signaling and Bone Fracture Healing$590,150
R01 · FY2018 · AR · contact PI
Growth Factor Based on Enhancement of Bone Repair$350,900
R01 · FY2018 · AR · contact PI
Notch Signaling and Bone Fracture Healing$350,900
R01 · FY2017 · AR · contact PI
Growth Factor Based on Enhancement of Bone Repair$345,664
R01 · FY2017 · AR · contact PI
Mechanisms underlying commitment and differentiation of progenitor cells during bone healing$239,250
R01 · FY2017 · AR · contact PI
Notch Signaling and Bone Fracture Healing$350,900
R01 · FY2016 · AR · contact PI
Anti TNF-alpha approach to treat Osteogenesis Imperfecta$210,540
R21 · FY2016 · AR · contact PI
Notch Signaling and Bone Fracture Healing$350,808
R01 · FY2015 · AR · contact PI
Anti TNF-alpha approach to treat Osteogenesis Imperfecta$175,313
R21 · FY2015 · AR · contact PI
Defining a Myofibroblast/Pericyte as a Mesenchymal Progenitor Cell$336,832
R01 · FY2014 · AR · contact PI
Defining a myofibroblast/pericyte as a mesenchymal progenitor cell$326,599
R01 · FY2013 · AR · contact PI
Defining a myofibroblast/pericyte as a mesenchymal progenitor cell$343,867
R01 · FY2012 · AR · contact PI
Defining a myofibroblast/pericyte as a mesenchymal progenitor cell$343,026
R01 · FY2011 · AR · contact PI
Evaluation of Osteocyte Dedifferentiation Process$199,368
R21 · FY2011 · AR · contact PI
Evaluation of Osteocyte Dedifferentiation Process$172,125
R21 · FY2010 · AR · contact PI
Strategy to assess the function of osteocyte restricted genes$72,520
R03 · FY2009 · AR · contact PI
Strategy to assess the function of osteocyte restricted genes$72,520
R03 · FY2008 · AR · contact PI
Strategy to assess the function of osteocyte restricted genes$74,000
R03 · FY2007 · AR · contact PI